Reuters – Drug developer Axovant Sciences Ltd said it would stop testing its lead drug in Alzheimer’s after it failed to meet the main goals of a late-stage trial, underlining the challenges in developing treatments for the memory-robbing disease.
The Regulatory Review – While highly autonomous vehicles hold the potential to solve some of the safety problems that the existing regulatory structure was designed to address, they introduce new safety concerns.
NPR – About 20 percent of teens said they have been diagnosed with at least one concussion. And nearly 6 percent said they've been diagnosed with more than one, according to a research letter published Tuesday.
Reuters – Intellipharmaceutics International Inc, said on Monday the U.S. Food and Drug Administration declined to approve its opioid painkiller in its current form, asking for more proof of the drug’s ability to prevent abuse.
GlobeNewswire – The global graphene market was valued at USD 32.0 million in 2016 and is expected to reach USD 193.68 million in 2022, growing at a compound annual growth rate of 35.0% between 2017 and 2022.
Reuters – A coalition of supporters of self-driving cars said that it will run ads this week in social media and Washington newspapers, in an effort to convince the U.S. Congress to adopt sweeping legislation to boost the nascent industry.